IRIS Institutional Research Information System - OPENBS Open Archive UniBS

BERRUTI, ALFREDO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 23.874
EU - Europa 7.251
AS - Asia 3.574
OC - Oceania 20
Continente sconosciuto - Info sul continente non disponibili 16
AF - Africa 12
SA - Sud America 8
Totale 34.755
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 23.822
UA - Ucraina 2.682
CN - Cina 2.275
DE - Germania 1.096
HK - Hong Kong 984
PL - Polonia 869
IT - Italia 801
IE - Irlanda 506
GB - Regno Unito 429
FI - Finlandia 387
FR - Francia 185
RU - Federazione Russa 119
IN - India 100
VN - Vietnam 80
SE - Svezia 71
TR - Turchia 61
CA - Canada 52
BE - Belgio 49
NL - Olanda 29
SG - Singapore 19
AU - Australia 18
JP - Giappone 18
EU - Europa 16
KR - Corea 11
IR - Iran 9
CH - Svizzera 6
DK - Danimarca 5
MU - Mauritius 5
CL - Cile 4
AZ - Azerbaigian 3
ES - Italia 3
GR - Grecia 3
BR - Brasile 2
LA - Repubblica Popolare Democratica del Laos 2
MA - Marocco 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
RO - Romania 2
TH - Thailandia 2
ZW - Zimbabwe 2
AL - Albania 1
AR - Argentina 1
BY - Bielorussia 1
CY - Cipro 1
EG - Egitto 1
FK - Isole Falkland (Malvinas) 1
GE - Georgia 1
HU - Ungheria 1
ID - Indonesia 1
IL - Israele 1
IQ - Iraq 1
IS - Islanda 1
KG - Kirghizistan 1
KW - Kuwait 1
KZ - Kazakistan 1
LU - Lussemburgo 1
MK - Macedonia 1
PK - Pakistan 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
TN - Tunisia 1
ZA - Sudafrica 1
Totale 34.755
Salva come PNG Salva come JPEG
Città #
Fairfield 4.225
Woodbridge 3.238
Houston 2.183
Ashburn 1.873
Jacksonville 1.873
Seattle 1.719
Cambridge 1.594
Ann Arbor 1.362
Wilmington 1.342
Hong Kong 980
Princeton 877
Warsaw 869
Chandler 727
Beijing 547
New York 515
Nanjing 469
Dublin 464
Helsinki 321
Dearborn 199
Brescia 188
Des Moines 186
Nanchang 186
San Diego 181
Shenyang 135
Changsha 134
Hebei 133
Milan 97
Shanghai 95
Jinan 86
Tianjin 82
Dong Ket 80
London 80
Jiaxing 67
Orange 56
Hangzhou 51
Kocaeli 51
Verona 49
Brussels 48
Kunming 47
San Francisco 43
Los Angeles 40
West Jordan 40
Washington 35
Rome 32
Ningbo 30
Toronto 29
Lanzhou 26
Nürnberg 26
Zhengzhou 25
Kilburn 24
Boardman 23
Haikou 23
Norwalk 23
Menlo Park 22
Naples 21
Lancaster 20
Pune 20
Guangzhou 19
San Mateo 19
Taizhou 19
Redwood City 17
Changchun 16
Augusta 15
Hefei 15
Leawood 15
North York 15
Acton 14
Chicago 13
New Bedfont 13
Falls Church 12
Chiswick 11
Fuzhou 11
Phoenix 11
Dalmine 10
Prescot 10
Walnut 10
Canberra 9
Gumyojicho 9
Ardabil 8
Indiana 8
Lappeenranta 8
Melbourne 8
Napoli 8
Cazzago San Martino 7
Southwark 7
Turin 7
Vignate 7
Westminster 7
Fukuoka 6
Hounslow 6
Livorno 6
Brooklyn 5
Falkenstein 5
Perugia 5
Redmond 5
Rende 5
Taiyuan 5
Wandsworth 5
Berlin 4
Frankfurt am Main 4
Totale 28.330
Salva come PNG Salva come JPEG
Nome #
GPNMB/OA protein increases the invasiveness of human metastatic prostate cancer cell lines DU145 and PC3 through MMP-2 and MMP-9 activity 230
Adrenocortical carcinoma xenograft in zebrafish embryos as model to study the in vivo cytotoxicity of abiraterone acetate 205
Disease-specific and general health-related quality of life in newly diagnosed prostate cancer patients: the Pros-IT CNR study 200
Antisecretive and Antitumor Activity of Abiraterone Acetate in Human Adrenocortical Cancer: A Preclinical Study. 179
Hepatoprotective effect of N-acetylcysteine in trabectedin-induced liver toxicity in patients with advanced soft tissue sarcoma 175
Panniculitis and vitiligo occurring during BRAF and MEK inhibitors combination in advanced melanoma patients: Potential predictive role of treatment efficacy 170
Eight‐week interval in flushing and locking port‐a‐cath in cancer patients: A single‐institution experience and systematic review 163
Biological effect of neoadjuvant androgen-deprivation therapy assessed on specimens from radical prostatectomy: a systematic review 160
Are we failing in treatment of adrenocortical carcinoma? Lights and shadows of molecular signatures 159
Comparative efficacy of palbociclib, ribociclib and abemaciclib for ER+ metastatic breast cancer: an adjusted indirect analysis of randomized controlled trials 155
Immunotherapy failure in adrenocortical cancer: where next? 153
Excess of second tumors in denosumab-treated patients: A metabolic hypothesis 151
Pros-IT CNR: an Italian prostate cancer monitoring project 146
Neoadjuvant treatment approach: The rosetta stone for breast cancer? 144
Outcome of EGFR-mutated adenocarcinoma NSCLC patients with changed phenotype to squamous cell carcinoma after tyrosine kinase inhibitors: A pooled analysis with an additional case 144
Topoisomerase 2α and thymidylate synthase expression in adrenocortical cancer 143
The guanine nucleotide exchange factor VAV2 as a new prognostic parameter in adrenocortical carcinoma 142
In vitro cytotoxicity of cabazitaxel in adrenocortical carcinoma cell lines and human adrenocortical carcinoma primary cell cultures☆ 142
Genetic Polymorphisms as Possible Factors Involved in the Onset of Anthracycline-Induced Cardiomyopathy 140
IN VITRO ANTITUMOR ACTIVITY OF PROGESTERONE IN HUMAN ADRENOCORTICAL CARCINOMA 140
Biological bases of radical prostatectomy in the management of prostate cancer patients with oligometastatic disease 140
Testosterone Levels and Prostate Cancer Prognosis: Systematic Review and Meta-analysis 138
Oral toxicity management in head and neck cancer patients treated with chemotherapy and radiation: Dental pathologies and osteoradionecrosis (Part 1) literature review and consensus statement 137
Adding metyrapone to chemotherapy plus mitotane for Cushing's syndrome due to advanced adrenocortical carcinoma 136
Regression of advanced neuroendocrine tumors among patients receiving placebo 135
The Circadian Rhythm of Breakthrough Pain Episodes in Terminally-ill Cancer Patients 132
Should Adjuvant Weekly Paclitaxel Be Considered Less Efficacious Than Anthracyclines Plus Cyclophosphamide for Lower Risk Patients With Early-Stage Breast Cancer? 130
Management of patients with castration-resistant prostate cancer (CRPC): results of an Italian survey using the delphi method 129
Palbociclib inhibits proliferation of human adrenocortical tumor cells 129
Osimertinib in EGFR Mutation–Positive Advanced NSCLC 127
Outcome of patients with lung adenocarcinoma with transformation to small-cell lung cancer following tyrosine kinase inhibitors treatment: A systematic review and pooled analysis 126
Inhibition of Survivin Is Associated with Zoledronic Acid-induced Apoptosis of Prostate Cancer Cells 124
When should everolimus be administered in the natural history of pancreatic neuroendocrine tumors? 122
Pathologic Complete Response As a Potential Surrogate for the Clinical Outcome in Patients With Breast Cancer After Neoadjuvant Therapy: A Meta-Regression of 29 Randomized Prospective Studies. 122
Amiloride Is Effective in the Management of Abiraterone-Induced Mineralocorticoid Excess Syndrome without Interfering with Its Antineoplastic Activity 121
Texture features of colorectal liver metastases on pretreatment contrast-enhanced CT may predict response and prognosis in patients treated with bevacizumab-containing chemotherapy: a pilot study including comparison with standard chemotherapy 121
Cytotoxic Effect of Trabectedin In Human Adrenocortical Carcinoma Cell Lines and Primary Cells 121
Adjuvant bisphosphonates in patients with breast cancer: Does the potency matter? 120
Exemestane with ovarian suppression in premenopausal breast cancer. 120
Association of Fat Body Mass With Vertebral Fractures in Postmenopausal Women With Early Breast Cancer Undergoing Adjuvant Aromatase Inhibitor Therapy 119
Serum vitamin D and prostate cancer prognosis: The story continues 118
Abiraterone acetate exerts a cytotoxic effect in human prostate cancer cell lines 118
Investigational drugs targeting somatostatin receptors for treatment of acromegaly and neuroendocrine tumors. 116
Abiraterone and prednisone therapy may cause severe hypoglycemia when administered to prostate cancer patients with type 2 diabetes receiving glucose-lowering agents 116
Prognostic factors in patients receiving third-line targeted therapy for metastatic renal cell carcinoma. 115
Management of Severe Cushing Syndrome Induced by Adrenocortical Carcinoma with Abiraterone Acetate: A Case Report 115
Hypoxia-related biological markers as predictors of epirubicinbased treatment responsiveness and resistance in locally advanced breast cancer 115
Molecular Drivers of Potential Immunotherapy Failure in Adrenocortical Carcinoma. 114
Morphometric vertebral fractures in breast cancer patients treated with adjuvant aromatase inhibitor therapy: A cross-sectional study 113
Abiraterone plus prednisone in metastatic, castration-sensitive prostate cancer 113
Anti-Angiogenic effect of tamoxifen combined with epirubicin in breast cancer patients 111
Circulating tumor cells in patients with recurrent or metastatic head and neck carcinoma: prognostic and predictive significance 111
Decision-making for adrenocortical carcinoma: surgical, systemic, and endocrine management options 110
Patient frailty predicts worse perioperative outcomes and higher cost after radical cystectomy worse radical cystectomy outcomes in frails 109
Clinical and histological prognostic factors of recurrent and/or metastatic salivary gland adenoid cystic carcinoma 109
Combination of letrozole, metronomic cyclophosphamide and sorafenib is well-tolerated and shows activity in patients with primary breast cancer. 108
Is time to first skeletal-related event the best primary end point in the assessment of bisphosphonate efficacy in patients with castration-sensitive prostate cancer? 108
Case-control study of the impact of adjuvant hormone therapy in prostate cancer patients on quality of life, anxiety and depression and self body image perception 108
Favorable response of metastatic adrenocortical carcinoma to etoposide, adriamycin and cisplatin (EAP) chemotherapy. Report of two cases. 108
Eribulin Treatment in Patients with Liver Metastatic Breast Cancer: Eight Italian Case Reports 108
Oral toxicity management in head and neck cancer patients treated with chemotherapy and radiation: Xerostomia and trismus (Part 2). Literature review and consensus statement 107
A Rare Complex BRAF Mutation Involving Codon V600 and K601 in Primary Cutaneous Melanoma: Case Report 107
The pathological diagnosis of neuroendocrine tumors: Common questions and tentative answers 106
Mediastinal non-seminomatous germ cell tumours: effectiveness of platinum, etoposide, bleomycin combination chemotherapy plus adjunctive surgery. 105
Evaluation by dual energy X-ray absorptiometry of changed bone density in metastatic bone sites as a consequence of systemic treatment. 104
IFN-α in advanced well-differentiated neuroendocrine tumors: The neglected drug? 104
Follow-up after gastrectomy for cancer: the Charter Scaligero Consensus Conference 104
Linsitinib (OSI-906) versus placebo for patients with locally advanced or metastatic adrenocortical carcinoma: A double-blind, randomised, phase 3 study 103
Predictive immunohistochemical biomarkers in the context of neoadjuvant therapy for breast cancer. 103
Urinary calcium excretion in the monitoring of bone metastases from prostatic carcinoma. 103
Cost-effectiveness of model-based eligibility for lung cancer screening in the routine clinical practice 103
MANAGEMENT OF ENDOCRINE DISEASE: Risk of overtreatment in patients with adrenal insufficiency: current and emerging aspects 103
An unusual case of a well-differentiated neuroendocrine tumour of the ileum with peritoneal carcinomatosis: A case report 102
Combination chemotherapy in advanced adrenocortical carcinoma 102
Second line treatment of recurrent glioblastoma with sunitinib: results of a phase II study and systematic review of literature 102
Follow-up and quality of life 102
Gemcitabine and vinorelbine as second-line treatment in patients with metastatic breast cancer: a phase II study. 102
Does nephrectomy during adrenalectomy for adrenal cancer improve oncological results? 101
Prognostic factors in stage III-IV adrenocortical carcinomas (ACC): An European Network for the Study of Adrenal Tumor (ENSAT) study 101
CT texture analysis as predictive factor in metastatic lung adenocarcinoma treated with tyrosine kinase inhibitors (TKIs) 101
Leptomeningeal metastasis from solid tumors: a diagnostic and therapeutic challenge. 101
RRM1 modulates mitotane activity in adrenal cancer cells interfering with its metabolization. 100
Acute myeloblastic leukemia associated with mediastinal nonseminomatous germ cell tumors. Report on two cases. 100
Gonadal function in male patients with metastatic renal cell cancer treated with sunitinib: Effects of testosterone replacement on quality of life. 100
5th International ACC Symposium: Future and Current Therapeutic Trials in Adrenocortical Carcinoma 100
Systemic Therapy in Locally Advanced or Metastatic Adrenal Cancers: A Critical Appraisal and Clinical Trial Update 100
Adjuvant mitotane treatment for adrenocortical carcinoma 99
Activity and safety of a prolonged daily schedule of zoledronic acid in a patient with bone metastases from urothelial carcinoma 99
Alberta Breakthrough Pain Assessment Tool: A validation multicentre study in cancer patients with breakthrough pain. 98
Real-world study of everolimus in advanced progressive neuroendocrine tumors. 98
Potential clinical value of circulating chromogranin A in patients with prostate carcinoma. 98
Analysis of Circulating Tumor Cells in Prostate Cancer Patients at PSA Recurrence and Review of the Literature 98
Effect of primary letrozole treatment on tumor expression of mTOR and HIF-1α and relation to clinical response 98
PROGNOSTIC ROLE OF SERUM TESTOSTERONE LEVELS IN PROSTATE CANCER PATIENTS DURING ANDROGEN-DEPRIVATION THERAPY 97
Variations along the 24-hour cycle of circulating osteoprotegerin and soluble RANKL: a rhythmometric analysis 97
Jaw osteonecrosis associated with intravenous bisphosphonate: is incidence reduced after adoption of dental preventive measures? 97
Abiraterone and increased survival in metastatic prostate cancer 97
European Society of Endocrinology Clinical Practice Guidelines on the management of adrenocortical carcinoma in adults, in collaboration with the European Network for the Study of Adrenal Tumors 97
Mitotane levels predict the outcome of patients with adrenocortical carcinoma treated adjuvantly following radical resection. 96
Idiopathic intracranial hypertension: A possible complication in the natural history of advanced prostate cancer. 96
Totale 12.064
Salva come PNG Salva come JPEG
Categoria #
all - tutte 166.918
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 166.918
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20192.205 0 0 0 0 0 0 0 0 0 0 1.194 1.011
2019/202010.514 1.300 346 405 1.154 721 1.256 1.096 1.167 1.038 1.093 336 602
2020/20217.447 202 836 390 849 400 774 392 783 618 1.171 649 383
2021/20223.499 274 702 93 212 50 182 214 233 194 349 266 730
2022/20232.586 496 83 74 178 191 711 12 212 347 44 115 123
2023/20243.142 180 97 317 217 206 696 109 145 1.049 120 6 0
Totale 35.673